Taipei-based Orient Europharma Group (OEP) and Japan's Nano Carrier Co. Ltd. inked a new license agreement on a pancreatic cancer drug yesterday, and unveiled their joint investment of NT$700 million (US$24 million) in a new plant to produce cancer drugs.
A drug initially developed to treat some types of cancer now appears to help people suffering from multiple sclerosis (MS), a study said Thursday.
Breast-cancer screening saves lives even though it also picks up cases in some women that would never have caused them a problem, according to a review published in The Lancet medical journal.
The Department of Health (DOH) yesterday gave an order to recall two instant noodle products from South Korea, which were found to contain traces of the cancer-causing substance benzopyrene.
A controversial study that linked genetically modified corn to cancer in lab rats is a “scientific non-event,” six French scientific academies said on Friday.
Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage.
America's favorite dietary supplements, multivitamins, modestly lowered the risk for cancer in healthy male doctors who took them for more than a decade, the first large study to test these pills has found.
A new study found marked molecular similarities between breast and ovarian cancer which scientists said could help lead to new treatments for hard-to-treat forms of breast cancer.
According to a survey conducted by the Department of Health in 2009, since May 2005, nearly 1,000 people have been diagnosed with kidney cancer every year. Among all forms of tumors, malignant tumors were found to be the most common cause of kidney cancer, as more than 90 percent of the patients were diagnosed with metastatic renal cell carcinoma over the past seven years.